Darifenacin hydrobromide

Details

Files

Generic Name:

Darifenacin hydrobromide

Project Status:

Complete

Therapeutic Area:

Bladder, overactive

Manufacturer:

Novartis Pharmaceuticals Canada Inc.

Brand Name:

Enablex

Project Line:

Reimbursement Review

Project Number:

SR0147-000

Performance Metric:

N/A — Predated performance metrics

Submission Type:

Resubmission

Indications:

Bladder, overactive

Recommendation Type:

List with clinical criteria and/or conditions

Final Recommendation:

April 16, 2009

Files

Submission Status Report View PDF

Recommendation and Reasons View PDF

Last Updated : October 1, 2008